Telomeres

Pay-to-play age reduction has $1m price tag

This is the world's first IRB-approved clinical trial aimed at reversing aging by at least 20 years; it is also the world's most expensive...

Telomeres extend lifespan without genetic mods

The Spanish National Cancer Research Centre (CNIO) have discovered a way for telomeres to extend the lifespan of mice without genetic modification. Scientists have been...

Telomere shortening tied to structural changes in the brain

Max Planck researchers find changes across mere months, that are possibly reversed by brain training by telomore shortening.  The tips of our chromosomes, known as...

New study reveals Telomerase in adult cells slows aging

Maryland and NIH researchers discover previously unknown function in enzyme, that slows cell aging. In a discovery that profoundly challenges our understanding of a vital...

Latest articles

Insurer puts down £20m to research an aging rethink

A new partnership between Legal & General and Edinburgh University aims to address the societal and economic implications of an aging society. The world is...

23andMe redundancies: DNA test market decline?

Could layoffs at 23andMe be a sign that the consumer appetite for genetic testing is declining? We expect consumer markets to transition to more...

Singapore agetech – ones to watch in 2020

Singapore thrives on its prime location at the crossroads of Asia's biggest markets, low business tax and great IT infrastructure; it is well-positioned to...

Innovating organ-on-chip to accelerate research

BIOFABICS brings custom design tools to biofabrication. While still in its infancy, organ-on-chip (OOC) technology is quickly becoming a key growth segment in the Longevity...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.